Table 1.
Serum anti-inflammatory cytokine Levels and CRP (ng/ml) amongst HIV infected subjects before commencement of HAART, 6 months into HAART and 1 year into HAART (±SD)
| Group | IL-4 (Pg/ml) | IL-10 (Pg/ml), | TGF-β (Pg/ml), |
|---|---|---|---|
| Before commencement of HAART {a} (n = 50) | 26.67 ± 4.39 | 31.57 ± 6.35 | 102.77 ± 30.53 |
| 6 Months into HAART{b} (n = 50) | 7.98 ± 6.93 | 18.47 ± 5.29 | 85.03 ± 28.33 |
| 1 Year into HAART{c} (n = 50) | 4.42 ± 2.11 | 7.05 ± 2.43 | 61.24 ± 22.08 |
| Control {d} (n = 50) | 3.68 ± 1.59 | 4.66 ± 2.12 | 39.20 ± 14.39 |
| F Value | 15.93 | 30.47 | 99.70 |
| P Value | 0.02 | 0.00 | 0.00 |
| {a} Vs {b} | P < 0.05 | P < 0.05 | P < 0.05 |
| {a} Vs {c} | P < 0.05 | P < 0.05 | P < 0.05 |
| {a} Vs {d} | P < 0.05 | P < 0.05 | P < 0.05 |
| {b} Vs {c} | P < 0.05 | P < 0.05 | P < 0.05 |
| {b} Vs {d} | P < 0.05 | P < 0.05 | P < 0.05 |
| {c} Vs {d} | P > 0.05 | P > 0.05 | P < 0.05 |
IL-4 Interleukin 4, IL-10 Interleukin 10, TGF-β Tissue Growth Factor Beta, HAART Highly Active Antiretroviral Therapy, Vs Versus